Literature DB >> 16007629

22q11.2 duplication syndrome: two new familial cases with some overlapping features with DiGeorge/velocardiofacial syndromes.

Marie-France Portnoï1, Fanny Lebas, Nicolas Gruchy, Azarnouche Ardalan, Valérie Biran-Mucignat, Valérie Malan, Lina Finkel, Gilles Roger, Sarah Ducrocq, Francis Gold, Jean-Louis Taillemite, Sandrine Marlin.   

Abstract

Twenty-one patients, including our two cases, with variable clinical phenotype, ranging from mild learning disability to severe congenital malformations or overlapping features with DiGeorge/velocardiofacial syndromes (DG/VCFS), have been shown to have a chromosome duplication 22q11 of the region that is deleted in patients with DG/VCFS. The reported cases have been identified primarily by interphase FISH and could have escaped identification and been missed by routine cytogenetic analysis. Here we report on two inherited cases, referred to us, to rule out 22q11 microdeletion diagnosis of VCFS. The first patient was a 2-month-old girl, who presented with cleft palate, minor dysmorphic features including short palpebral fissures, widely spaced eyes, long fingers, and hearing loss. Her affected mother had mild mental retardation and learning disabilities. The second patient was a 7(1/2)-year-old boy with velopharyngeal insufficiency and mild developmental delay. He had a left preauricular tag, bifida uvula, bilateral fifth finger clinodactyly, and bilateral cryptorchidism. His facial features appeared mildly dysmorphic with hypertelorism, large nose, and micro/retrognathia. The affected father had mild mental retardation and had similar facial features. FISH analysis of interphase cells showed three TUPLE1-probe signals with two chromosome-specific identification probes in each cell. FISH analysis did not show the duplication on the initial testing of metaphase chromosomes. On review, band q11.2 was brighter on one chromosome 22 in some metaphase spreads. The paucity of reported cases of 22q11.2 microduplication likely reflects a combination of phenotypic diversity and the difficulty of diagnosis by FISH analysis on metaphase spreads. These findings illustrate the importance of scanning interphase nuclei when performing FISH analysis for any of the genomic disorders. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16007629     DOI: 10.1002/ajmg.a.30847

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  34 in total

1.  Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications.

Authors:  J Wincent; D L Bruno; B W M van Bon; A Bremer; H Stewart; E M H F Bongers; C W Ockeloen; M H Willemsen; D D A Keays; G Baird; D F Newbury; T Kleefstra; C Marcelis; U Kini; Z Stark; R Savarirayan; L J Sheffield; O Zuffardi; H R Slater; B B de Vries; S J L Knight; B-M Anderlid; J Schoumans
Journal:  Mol Syndromol       Date:  2011-05-18

2.  22q11.2 Microduplications: Two Clinical Reports Compared with Similar Cases from the Literature.

Authors:  Aderonke Oyetunji; Merlin G Butler
Journal:  J Pediatr Genet       Date:  2020-01-10

3.  MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.

Authors:  J A S Vorstman; G R Jalali; E F Rappaport; A M Hacker; C Scott; B S Emanuel
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

4.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

5.  A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies.

Authors:  Anthony L Gotter; Manjunath A Nimmakayalu; G Reza Jalali; April M Hacker; Jacob Vorstman; Danielle Conforto Duffy; Livija Medne; Beverly S Emanuel
Journal:  Genome Res       Date:  2007-03-09       Impact factor: 9.043

6.  Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region.

Authors:  Justine Coppinger; Donna McDonald-McGinn; Elaine Zackai; Kate Shane; Joan F Atkin; Alexander Asamoah; Robert Leland; David D Weaver; Susan Lansky-Shafer; Karen Schmidt; Heidi Feldman; William Cohen; Judy Phalin; Berkley Powell; Blake C Ballif; Aaron Theisen; Elizabeth Geiger; Chad Haldeman-Englert; Tamim H Shaikh; Sulagna Saitta; Bassem A Bejjani; Lisa G Shaffer
Journal:  Hum Mol Genet       Date:  2009-02-03       Impact factor: 6.150

7.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Authors:  Noboru Hiroi; Hongwen Zhu; Moonsook Lee; Birgit Funke; Makoto Arai; Masanari Itokawa; Raju Kucherlapati; Bernice Morrow; Takehito Sawamura; Soh Agatsuma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

8.  Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice.

Authors:  Go Suzuki; Kathryn M Harper; Takeshi Hiramoto; Birgit Funke; MoonSook Lee; Gina Kang; Mahalah Buell; Mark A Geyer; Raju Kucherlapati; Bernice Morrow; Pekka T Männistö; Soh Agatsuma; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

9.  Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome.

Authors:  Chen Yang; Cheng-Hung Huang; Mei-Leng Cheong; Kun-Long Hung; Lung-Huang Lin; Yeong-Seng Yu; Chih-Cheng Chien; Huei-Chen Huang; Chan-Wei Chen; Chi-Jung Huang
Journal:  BMC Med Genet       Date:  2009-02-25       Impact factor: 2.103

Review 10.  A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review.

Authors:  Luis Fernández; Julián Nevado; Fernando Santos; Damià Heine-Suñer; Victor Martinez-Glez; Sixto García-Miñaur; Rebeca Palomo; Alicia Delicado; Isidora López Pajares; María Palomares; Luis García-Guereta; Eva Valverde; Federico Hawkins; Pablo Lapunzina
Journal:  BMC Med Genet       Date:  2009-06-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.